Fasedienol Nasal Spray Reduces Anxiety Symptoms in Patients With Social Anxiety Disorder

Top-line results were announced from a phase 3 study evaluating fasedienol (PH94B) nasal spray in adults diagnosed with social anxiety disorder.

Related Keywords

New York ,United States ,Columbia University ,New York State Psychiatric Institute ,Michaelr Liebowitz , ,Research Network ,York State Psychiatric Institute ,Liebowitz Social Anxiety Scale ,Subjective Units ,Distress Scale ,Clinical Global Impression Improvement ,Anxiety Disorders Clinic ,Managing Director ,Medical Research Network ,